- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06303323
Comparative Effectiveness of Qigong Exercise Versus Wu Dang Tai Chi Chuan in CVD Risk Individuals
Comparative Effectiveness of Qigong Exercise Versus Wu Dang Tai Chi Chuan on Exercise Capacity and Stress in CVD Risk Individuals
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Punjab
-
Rawalpindi, Punjab, Pakistan, 4600
- Pakistan Railway General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- According to the Framingham risk calculator 10% to 20%+ for moderate to high-risk
- Patients at risk of CVD (last 6 months)
- Patients with either HTN, dyslipidemia, or diabetes
- Patients with less than 45 scores on the Berg Balance scale
- Stress from moderate to severe on PSS
- No regular physical exercise for at least 1 year
- Willing to take part
Exclusion Criteria:
- History of stroke
- CVD
- Acute Infection
- Acute injury
- Any diagnosed psychological issue
- MSK disorders
- Member of marital arts/dance
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Qigong Exercise
Baduanjin Exercise will be performed which consists of 8 standing postures.
At least 30 minutes per time.
10-13 min for a set of Badaunjin
|
Baduanjin Exercise will be performed which consists of 8 standing postures. At least 30 minutes per time. 10-13 min for a set of Badaunjin. In the first 2 weeks, two sets of Baduanjin will be performed. Total Duration: 6 weeks Frequency: for 3 days/week. (alternative days) Intensity: low-intensity exercise Total Time: 50 Minutes Type: aerobic training |
|
Experimental: Wu Dang Tai Chi
Wu Dang 13 form postures will be performed.
Initially, each posture will be performed 3 times then progressively increase to more according to the patient's discomfort.
|
Wu Dang 13 form postures will be performed. Initially, each posture will be performed 3 times then progressively increase to more according to the patient's discomfort. Total Duration: 6 weeks Frequency: 3 times/ week (alternative day ) Intensity: Low to Moderate Intensity Time: 50 Minutes Type: aerobic training |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Exercise Capacity
Time Frame: 6 weeks
|
Changes from baseline to 6 weeks after the intervention, measured through 6 min walk test (6 MWT).
It is a submaximal exercise test that can aid in assessing the functional/exercise capacity of patients with cardiopulmonary diseases, in this test we find out the maximum distance in meters that an individual covers in 6 min without any support.
|
6 weeks
|
|
Stress
Time Frame: 6 weeks
|
Changes from baseline to 6 weeks after the intervention, measured through Perceived Stress Scale. Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress. Scores ranging from 0-13 would be considered low stress. Scores ranging from 14-26 would be considered moderate stress. |
6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mehwish Waseem, MSPT-CPPT, Riphah International University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Rec/01816 Nawal Fatima
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Qigong Exercise
-
McGill UniversityJewish General HospitalTerminatedCarcinoma, Non-Small-Cell Lung | Cancer of the Gastrointestinal TractCanada
-
The Hospital for Sick ChildrenCompletedFibromyalgia | Muscular DiseaseCanada
-
Eman Mohamed othmanNot yet recruiting
-
Charite University, Berlin, GermanyCompleted
-
Akdeniz UniversityCompletedQuality of Life | Postoperative Pain | Muscle Weakness | Pain, Shoulder | Respiratory Function Loss | Joint AdhesionTurkey
-
Cairo UniversityNot yet recruitingMastectomy; LymphedemaEgypt
-
The University of Hong KongUnknown
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Spaulding Rehabilitation HospitalCompletedBreast Cancer | Breast Cancer Surgery Pain | Stage 0-III Breast CancerUnited States
-
The University of Hong KongCompleted
-
University of Kansas Medical CenterActive, not recruiting